pantoprazole has been researched along with Sensitivity and Specificity in 19 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the sensitivity and specificity of intensive empirical treatment with pantoprazole in diagnosing laryngopharyngeal reflux in adults." | 7.77 | Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. ( Marina, MB; Masaany, M; Sani, A; Sharifa Ezat, WP, 2011) |
| "Pantoprazole 40 mg was at least as effective as esomeprazole 40 mg for relieving GERD symptoms." | 6.73 | Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. ( Abdel-Qader, M; Gatz, G; Glatzel, D; Pfaffenberger, B, 2007) |
| "To determine the sensitivity and specificity of intensive empirical treatment with pantoprazole in diagnosing laryngopharyngeal reflux in adults." | 3.77 | Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. ( Marina, MB; Masaany, M; Sani, A; Sharifa Ezat, WP, 2011) |
| "Pantoprazole 40 mg was at least as effective as esomeprazole 40 mg for relieving GERD symptoms." | 2.73 | Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. ( Abdel-Qader, M; Gatz, G; Glatzel, D; Pfaffenberger, B, 2007) |
| " Both drugs induced similar false-negative UBTs on day 14 of dosing (P = 0." | 2.71 | Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test. ( Biagini, R; Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansi, C; Mele, MR; Savarino, V; Tessieri, L; Usai, P; Vigneri, S; Zentilin, P, 2003) |
| " The method was demonstrated with acceptable accuracy, precision, selectivity, and stability and the method was applied to support a pharmacokinetic study of a phase I clinical trial of racemic pantoprazole in healthy Chinese subjects." | 1.43 | High-Throughput Chiral LC-MS/MS Method Using Overlapping Injection Mode for the Determination of Pantoprazole Enantiomers in Human Plasma with Application to Pharmacokinetic Study. ( Hong, Z; Jiang, H; Li, S; Liang, W; Liu, Y; Shen, X; Wang, Y, 2016) |
| " The developed assay method was applied to a pharmacokinetic study in human volunteers." | 1.35 | Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. ( Bharathi, DV; Chatki, PK; Hotha, KK; Jagadeesh, B; Mullangi, R; Naidu, A; Thriveni, K, 2009) |
| "Pantoprazole is an important drug in the treatment of acid-related disorders." | 1.33 | Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. ( Colomé, LM; Guterres, SS; Pohlmann, AR; Raffin, RP, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yehia, AM | 1 |
| Li, S | 1 |
| Jiang, H | 1 |
| Wang, Y | 1 |
| Liu, Y | 1 |
| Shen, X | 1 |
| Liang, W | 1 |
| Hong, Z | 1 |
| Bharathi, DV | 1 |
| Hotha, KK | 1 |
| Jagadeesh, B | 1 |
| Chatki, PK | 1 |
| Thriveni, K | 1 |
| Mullangi, R | 1 |
| Naidu, A | 1 |
| Challa, BR | 1 |
| Boddu, SH | 1 |
| Awen, BZ | 1 |
| Chandu, BR | 1 |
| Bannoth, CK | 1 |
| Khagga, M | 1 |
| Kanala, K | 1 |
| Shaik, RP | 1 |
| Masaany, M | 1 |
| Marina, MB | 1 |
| Sharifa Ezat, WP | 1 |
| Sani, A | 1 |
| Barreiro, JC | 1 |
| Vanzolini, KL | 1 |
| Cass, QB | 2 |
| Venugopal, N | 1 |
| Bhaskar Reddy, AV | 1 |
| Gangadhar Reddy, K | 1 |
| Madhavi, V | 1 |
| Madhavi, G | 1 |
| Chen, M | 1 |
| Xia, Y | 1 |
| Ma, Z | 1 |
| Li, L | 1 |
| Zhong, D | 1 |
| Chen, X | 1 |
| Dulbecco, P | 1 |
| Gambaro, C | 1 |
| Bilardi, C | 1 |
| Zentilin, P | 1 |
| Mele, MR | 1 |
| Mansi, C | 1 |
| Biagini, R | 1 |
| Tessieri, L | 1 |
| Iiritano, E | 1 |
| Usai, P | 1 |
| Vigneri, S | 1 |
| Savarino, V | 1 |
| Plante, L | 1 |
| Ferron, GM | 1 |
| Unruh, M | 1 |
| Mayer, PR | 1 |
| Ramakrishna, NV | 1 |
| Vishwottam, KN | 1 |
| Wishu, S | 1 |
| Koteshwara, M | 1 |
| Raffin, RP | 1 |
| Colomé, LM | 1 |
| Pohlmann, AR | 1 |
| Guterres, SS | 1 |
| Rahman, N | 1 |
| Bano, Z | 1 |
| Azmi, SN | 1 |
| Sivakumar, T | 1 |
| Manavalan, R | 1 |
| Muralidharan, C | 1 |
| Valliappan, K | 1 |
| Reddy, VR | 1 |
| Rajmohan, MA | 1 |
| Shilpa, RL | 1 |
| Raut, DM | 1 |
| Naveenkumar, K | 1 |
| Suryanarayana, MV | 1 |
| Mathad, VT | 1 |
| Glatzel, D | 1 |
| Abdel-Qader, M | 1 |
| Gatz, G | 1 |
| Pfaffenberger, B | 1 |
| Guan, J | 1 |
| Yang, J | 1 |
| Bi, Y | 1 |
| Shi, S | 1 |
| Yan, F | 1 |
| Li, F | 1 |
| Degani, AL | 1 |
| Cassiano, NM | 1 |
| Pedrazolli, J | 1 |
| Parente, F | 1 |
| Sainaghi, M | 1 |
| Sangaletti, O | 1 |
| Imbesi, V | 1 |
| Maconi, G | 1 |
| Anderloni, A | 1 |
| Bianchi Porro, G | 1 |
3 trials available for pantoprazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Breath Tests; Dose-Response Relations | 2003 |
Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Cross-Over Studies; Dose-Response Relationship | 2007 |
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Car | 2002 |
16 other studies available for pantoprazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Development and validation of new spectrophotometric ratio H-point standard addition method and application to gastrointestinal acting drugs mixtures.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzamides; Benzyl Compounds; Gastrointestinal Agents; Morp | 2013 |
High-Throughput Chiral LC-MS/MS Method Using Overlapping Injection Mode for the Determination of Pantoprazole Enantiomers in Human Plasma with Application to Pharmacokinetic Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Chromatography, Liquid; Drug Stability; High-Through | 2016 |
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Human | 2009 |
Development and validation of a sensitive bioanalytical method for the quantitative estimation of pantoprazole in human plasma samples by LC-MS/MS: application to bioequivalence study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Area Under Curve; Chromatography, Liq | 2010 |
Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Body Mass Index; Double-Blind Method; En | 2011 |
Direct injection of native aqueous matrices by achiral-chiral chromatography ion trap mass spectrometry for simultaneous quantification of pantoprazole and lansoprazole enantiomers fractions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humic Substances; Lansoprazole; Least-Squares Analysis; Pan | 2011 |
Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetates; Acetonitriles; Buffers; Calibration; Chromatograp | 2012 |
Validation of a chiral liquid chromatography-tandem mass spectrometry method for the determination of pantoprazole in dog plasma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Chromatography, Liquid; Dogs; Drug Stability; Line | 2012 |
Excretion of pantoprazole in human breast.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Biological Transport, Active; Breast | 2004 |
High-performance liquid chromatography method for the quantification of pantoprazole in human plasma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography, High Pressure Liquid; Human | 2005 |
Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Calorimetry, Di | 2006 |
Kinetic spectrophotometric analysis of pantoprazole in commercial dosage forms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ferricyanides; Ferrocyanides; Hydrogen-Ion Concentration; I | 2006 |
Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetonitriles; Analysis of Variance; Anti-Ulcer Agents; Cal | 2007 |
A novel quantification method of pantaprazole sodium monohydrate in sesquihydrate by thermogravimetric analyzer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Calibration; Calorimetry, Differential S | 2007 |
Determination of the enantiomeric impurity in S-(-)pantoprazole using high performance liquid chromatography with sulfobutylether-beta-cyclodextrin as chiral additive.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; beta-Cyclodextrins; Chromatography, High | 2008 |
Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Calibration; Chromatography, High Pressure | 2002 |